{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:32:43Z","timestamp":1791228763280,"version":"4.1.0"},"reference-count":11,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1080\/14660820410019602","type":"journal-article","created":{"date-parts":[[2004,6,7]],"date-time":"2004-06-07T15:41:35Z","timestamp":1086622895000},"page":"107-117","source":"Crossref","is-referenced-by-count":101,"title":["Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials"],"prefix":"10.1080","volume":"5","author":[{"given":"Vincent","family":"Meininger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Bensimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter G","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Douillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucette","family":"Lacomblez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nigel Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Robberecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,10]]},"reference":[{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Swash M, Schwartz MS. Motor neuron disease: the clinical syndrome. In: Leigh PN, Swash M, eds. Motor Neuron Disease: Biology and ManagementLondon: Springer Verlag 1995: 1\u201317.","DOI":"10.1007\/978-1-4471-1871-8_1"},{"key":"CIT0003","first-page":"226","volume":"13","author":"Tysnes OB","year":"1994","journal-title":"Prognostic factors and survival in amyotrophic lateral sclerosisNeuroepidemiol"},{"key":"CIT0004","first-page":"1425","volume":"347","author":"Lacomblez L","year":"1996","journal-title":"Dose- ranging study of riluzole in amyotrophic lateral sclerosisLancet"},{"key":"CIT0005","first-page":"585","volume":"330","author":"Bensimon G","year":"1994","journal-title":"A controlled trial of riluzole in amyotrophic lateral sclerosisN Engl J Med"},{"key":"CIT0008","first-page":"139","volume":"127","author":"Labie C","year":"1999","journal-title":"Effect of the neuropro- tective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortexBr J Pharmacol"},{"key":"CIT0009","first-page":"811","volume":"124","author":"Duong F","year":"1998","journal-title":"The effect of the nonpeptide neurotrophic compound SR57746A on the progression of the disease state of the pmn mouseBr J Pharmacol"},{"key":"CIT0016","first-page":"187","volume":"34","author":"Cox DR.","year":"1972","journal-title":"Regression models and life-tablesJ R Stat Soc [B]"},{"key":"CIT0017","first-page":"1079","volume":"40","author":"O\u2019Brien PC.","year":"1984","journal-title":"Procedures for comparing samples with multiple endpointsBiometrics"},{"key":"CIT0019","first-page":"1311","volume":"52","author":"Miller RG","year":"1999","journal-title":"Gelinas D et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review)Neurology"},{"issue":"1","key":"CIT0023","first-page":"66","volume":"50","author":"Stambler N","year":"1998","journal-title":"ALS CNTF Treatment Study GroupNeurology"},{"key":"CIT0024","first-page":"2040","volume":"57","author":"Bourke SC","year":"2001","journal-title":"sleep- disordered breathing as predictors of QOL in ALSNeurology"}],"container-title":["Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14660820410019602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T03:50:12Z","timestamp":1497585012000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14660820410019602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,7,10]]},"published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1080\/14660820410019602"],"URL":"https:\/\/doi.org\/10.1080\/14660820410019602","relation":{},"ISSN":["1466-0822"],"issn-type":[{"value":"1466-0822","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}